Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kristian Bolanos"'
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Progress toward improved solid-tumor treatment has long been hindered by the lack of truly tumor-specific targets. We have developed an approach to T cell therapy based on a dual-receptor system called Tmod™ that addresses this problem. The Tmod sy
Externí odkaz:
https://doaj.org/article/0a72d8b22eed4337b8c4f8952a58f533
Autor:
Breanna DiAndreth, Kiran Deshmukh, Jee-Young Mock, Talar Tokatlian, Alexander Kamb, Shruti Sharma, Grace E Asuelime, Dora Toledo Warshaviak, Mark E Daris, Kristian Bolanos, Breanna L Luna, Martin S Naradikian, Agnes E Hamburger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/b49783de028b41c1864f6aaaa8be401c
Autor:
Talar Tokatlian, Grace E Asuelime, Jee-Young Mock, Breanna DiAndreth, Shruti Sharma, Dora Toledo Warshaviak, Mark E Daris, Kristian Bolanos, Breanna L Luna, Martin S Naradikian, Kiran Deshmukh, Agnes E Hamburger, Alexander Kamb
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
BackgroundMesothelin (MSLN) is a classic tumor-associated antigen that is expressed in lung cancer and many other solid tumors. However, MSLN is also expressed in normal mesothelium which creates a significant risk of serious inflammation for MSLN-di
Autor:
Maria Imun, Mark L. Sandberg, Yuta Ando, Wen-Hua Lee, Xueyin Wang, Fernando Fisher, Michele McElvain, Kiran Deshmukh, Agnes E. Hamburger, Han Xu, Lu-Min Wong, Chuck Li, Breanna DiAndreth, Alexander Kamb, David M.C. Ju, Grant B Gabrelow, Dora Toledo-Warshaviak, Sanam Shafaattalab, Daniel P Nampe, Talar Tokatlian, Mark E. Daris, Shruti Sharma, Edwin Liu, Jee-Young Mock, Martin S. Naradikian, Kristian Bolanos-Ibarra, Aaron D. Martin, Grace E. Asuelime
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A131-A131
BackgroundMesothelin (MSLN) and carcinoembryonic antigen (CEA) are classic tumor-associated antigens that are expressed in many solid tumors including the majority of lung, colorectal and pancreatic cancers. However, both MSLN and CEA are also expres